Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.
Applications of high-resolution magic angle spinning MRS in biomedical studies II-Human diseases.
复制标题
高分辨率魔角旋转MRS在生物医学研究中的应用II-人类疾病
DOI:
10.1002/nbm.3784
复制
发表时间:
2017-11
影响因子:
2.9
通讯作者:
Cheng LL
中科院分区:
文献类型:
--
作者:
Dietz C;Ehret F;Palmas F;Vandergrift LA;Jiang Y;Schmitt V;Dufner V;Habbel P;Nowak J;Cheng LL
High-resolution magic angle spinning (HRMAS) magnetic resonance spectroscopy (MRS) is a powerful method for gaining insight into the physiological and pathological processes of cellular metabolism. Given its ability to obtain high resolution spectra of non-liquid biological samples, while preserving tissue architecture for subsequent histopathological analysis, the technique has become invaluable for biochemical and biomedical studies. Using HRMAS MRS, alterations in measured metabolites, metabolic ratios, and metabolomic profiles present the possibility to improve identification and prognostication of various diseases and decipher the metabolomic impact of drug therapies. In this review, we evaluate HRMAS MRS results on human tissue specimens from malignancies and non-localized diseases reported in the literature since the inception of the technique in 1996. We present the diverse applications of the technique in understanding pathological processes of different anatomical origins, correlations with in vivo imaging, effectiveness of therapies, and progress in the HRMAS methodology. High resolution magic angle spinning (HRMAS) magnetic resonance spectroscopy (MRS) is a method which enhances resolution for non-liquid biological samples. Since its introduction in 1996, HRMAS has been used in a wide variety of biomedical and biochemical studies and is one of the major techniques used in metabolomic analysis. In this review, HRMAS results on human tissue malignancies and non-localized diseases are evaluated, with discussions of applications for understanding pathological processes, correlations with in vivo imaging, therapy effectiveness, and methodology progress.
登录
查看更多内容
影响因子:
3.8
作者:
Borgan E;Sitter B;Lingjærde OC;Johnsen H;Lundgren S;Bathen TF;Sørlie T;Børresen-Dale AL;Gribbestad IS
通讯作者:
Gribbestad IS
DOI:
10.1016/s0360-3016(01)01630-3
发表时间:
2001-10-01
影响因子:
7
作者:
Brizel, DM;Schroeder, T;Mueller-Klieser, W
通讯作者:
Mueller-Klieser, W
影响因子:
3.8
作者:
Cao MD;Giskeødegård GF;Bathen TF;Sitter B;Bofin A;Lønning PE;Lundgren S;Gribbestad IS
通讯作者:
Gribbestad IS
影响因子:
5.2
作者:
Andronesi, Ovidiu C.;Blekas, Konstantinos D.;Tzika, A. Aria
通讯作者:
Tzika, A. Aria
影响因子:
15.9
作者:
Cheng, LL;Anthony, DC;Gonzalez, RG
通讯作者:
Gonzalez, RG